Kintai Therapeutics launches to tackle the interface between the gut, immune system, and brain

Saturday, April 20, 2019 - 07:00 in Biology & Nature

The start-up, founded by Flagship Pioneering, is developing small-molecule drugs aimed at the gut microbiome, gut immune cells, and enteric nervous system

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net